Chen Ling-Xin, Koyner Jay L
Section of Nephrology, Department of Medicine, University of Chicago, 5841 South Maryland Avenue, Suite S-504, MC 5100, Chicago, IL 60637, USA.
Section of Nephrology, Department of Medicine, University of Chicago, 5841 South Maryland Avenue, Suite S-504, MC 5100, Chicago, IL 60637, USA.
Crit Care Clin. 2015 Oct;31(4):633-48. doi: 10.1016/j.ccc.2015.06.002. Epub 2015 Jul 29.
Acute kidney injury (AKI) is a common and often lethal complication that is also associated with severe morbidity in hospitalized patients. During the last decade, the standardization of AKI diagnostic criteria has helped to facilitate several large-scale investigations of biomarkers of AKI. These studies have led to the international clinical implementation of several biomarkers of renal injury. This review summarizes the results of many of these multicenter investigations and discusses the clinical utility and interpretation of several of these new clinical tests. The merits of combining biomarkers of kidney function is also discussed.
急性肾损伤(AKI)是一种常见且往往致命的并发症,在住院患者中还与严重的发病率相关。在过去十年中,AKI诊断标准的标准化有助于推动对AKI生物标志物的多项大规模研究。这些研究已促成了几种肾损伤生物标志物在国际上的临床应用。本综述总结了许多此类多中心研究的结果,并讨论了其中几种新临床试验的临床效用及解读。还讨论了联合使用肾功能生物标志物的优点。